The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
Small ubiquitin-like modifier (SUMO) is a highly conserved post-translational modification protein, mainly found in eukaryotes. They are widely expressed in different tissues, including the liver. As an essential post-translational modification, SUMOylation is involved in many necessary regulations...
Guardado en:
Autores principales: | Hongchao Yuan, Yuanjun Lu, Yau-Tuen Chan, Cheng Zhang, Ning Wang, Yibin Feng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b46eb3ef2854148a2d30514748ac8c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021) -
Surgical Treatment of Postoperative Abdominal Metastases of Hepatocellular Carcinoma: 10-Year Experience in a Single Center
por: Fang J, et al.
Publicado: (2021) -
Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma
por: Sheryl Rodriguez, et al.
Publicado: (2021) -
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
por: Wentao Jia, et al.
Publicado: (2021) -
Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Saleh A. Alqahtani, et al.
Publicado: (2021)